With one headline, Pfizer had gone from being a well-known hunter — spending heavily to buy rivals — to the hunted.
Since 2011, Starboard Value's Jeff Smith has extracted board seats and profits from corporate America — by force if necessary ...
Activist investor Starboard Value may not be able to do much to help Pfizer Inc. (NYSE:PFE), according to a Wells Fargo ...
The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback